http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2358354-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d5bb9b9a6d998b72b154ceb1895a3f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87bf1f928974b6d665abc3e19c8a82eb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38 |
| filingDate | 2006-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6999c78313387e099e733c153831e44b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_560cfe07d6fc0405019f953aa558b875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd0c4015ffa2f6b5fb6052df60128695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba26b07fc3f8c85a5f44b7789491991c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f12a9cb60a4517a318d99b2e4967acd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9da38698e0802390cc02305ede48188 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a1e6f540fa6d97324c94c27e4f74168 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6f32da2d6f145da39a645a83c850b6d |
| publicationDate | 2011-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2358354-T3 |
| titleOfInvention | USEFUL AZACITOSINE DERIVATIVES AS ANTIVIRAL AGENTS. |
| abstract | An azacytosine derivative according to structural formula (I) or formula (III), a stereochemically isomeric form, a solvate, a salt, a 5,6-dihydro derivative thereof: ** (See formula) ** in which R1 R2 - and are independently selected from the group consisting of hydrogen, C1-30 alkyl, C2-30 alkenyl, C2-30 alkynyl, aryl, C1-30 alkylphenyl and C1-30 arylalkyl in which each of said alkyl C1-30, C2-30 alkenyl or C2-30 alkynyl optionally contains one or more heteroatoms selected from the group consisting of oxygen, nitrogen and sulfur in the main chain and / or is optionally substituted by one or more substituents selected from the group constituted by hydroxy, oxo and halogen or R1 and R2 are linked by one or more bonds to form a five, six or seven member ring comprising P, X1 and X2, said ring being optionally fused to a phenyl ring; -X1 is selected from the group consisting of NR4 and oxygen; -X2 is selected from the group consisting of NR5 and oxygen; R4 R5 - and are independently selected from the group consisting of hydrogen, C1-30 alkyl, C2-30 alkenyl and C2-30 alkynyl, wherein each of said C1-30 alkyl, C2-30 alkenyl or C2-30 alkynyl optionally it contains one or more heteroatoms selected from the group consisting of oxygen, nitrogen and sulfur in the main chain and / or is optionally substituted by one or more substituents selected from the group consisting of hydroxy and halogen; -Y is hydrogen or is a bond that binds oxygen to phosphorus to form a six-membered cyclic phosphonic acid ester; - each one, when Yeshydrogen, one is 1, and the other is 0 when Y is a bond that binds oxygen to phosphorus to form a 6-membered cyclic phosphonic acid ester; R3 - is selected from the group consisting of hydrogen, C1-4 alkyl, aryl, C1-4 arylalkyl, amino, hydroxy, CO2H, CO2R, CONH2, NR2, CONR2; and - R is a C1-30 alkyl. |
| priorityDate | 2005-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 734.